PMID: 696439Jan 1, 1978Paper

Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy

Acta neurochirurgica
W D Heiss

Abstract

Postoperative survival times of patients suffering from glioblastoma (astrozytoma III-IV) were compared in unselected groups receiving different forms of therapy: standard surgical therapy (16 cases, mean survival time 6.27 +/- 3.75 months), postoperative polychemotherapy (16 patients, survival time 8.96 +/- 4.97 months) or postoperative CCNU-monotherapy (24 cases, survival time 6.98 +/- 4.46 months). The mean survival time in the group receiving polychemotherapy was prolonged significantly when compared to the group with standard treatment. Survival time of the patient group treated with CCNU was not significantly increased. The results indicate that postoperative combination chemotherapy is more effective than CCNU monotherapy.

References

Aug 1, 1975·Journal of Neurosurgery·J CalogeroK J Enot
Jan 1, 1972·Progress in Experimental Tumor Research·L E Broder, D P Rall
Nov 1, 1967·Journal of Neurosurgery·R Jelsma, P C Bucy
Jul 1, 1972·Journal of Neurosurgery·T HoshinoD Fewer
Oct 30, 1972·JAMA : the Journal of the American Medical Association·D FewerM R Powell
Sep 1, 1973·Journal of Neurosurgery·M L RosenblumM D Walker
Sep 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J HildebrandY Kenis
Feb 1, 1972·Journal of Neurosurgery·M L SchwartzH J Hoffman
Jan 1, 1965·Acta neurochirurgica·G SimonH Hundeshagen
Jul 1, 1967·Journal of Neurosurgery·E A BeringH A Norrell
Jan 1, 1960·The Journal of Pathology and Bacteriology·R A WILLIS
Oct 1, 1962·Journal of Neuropathology and Experimental Neurology·E K ADRIAN, B E WALKER

❮ Previous
Next ❯

Related Concepts

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
W D HeissB Mamoli
© 2021 Meta ULC. All rights reserved